Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
Brings federal, state, regulatory, and legislative experience to NACDS’ advocacy on priority pharmacy reimbursement issues that are vital for patient access.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
The National Association of Chain Drug Stores (NACDS)-backed move — which will greatly enhance patients’ access to hearing aids — comes out of a final rule issued by the Food and Drug Administration (FDA) in mid-August.
The National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS), the Oklahoma Pharmacists Association (OPA) and American Pharmacies (APRx) issued the following joint press release today.
Former Assistant Secretary for Health in the Department of Health and Human Services and member of the White House Coronavirus Task Force demonstrated tremendous leadership on front lines of COVID-19 response
Hurricane Ian struck Florida as a powerful Category 4 hurricane on September 28, leaving widespread damage in its wake. NACDS member companies have been affected by the storm and—in collaboration with public health partners and emergency preparedness authorities— are working to meet the ongoing needs of people affected by the hurricane.
Exhibitors at the National Association of Chain Drug Stores (NACDS) Total Store Expo, held August 27-29 at the Boston Convention & Exhibition Center (BCEC), donated thousands of consumer goods to be dispersed to local non-profit organizations.
NACDS 2023 is the Association’s commitment to sustain a pro-pharmacy, pro-patient focus while also advancing broad health and wellness solutions throughout the store, through multidisciplinary care, and through community partnerships.
Comments to Centers for Medicare & Medicaid Services call for enforcement of electronic prescribing of controlled substances requirements no later than January 1, 2023.
